Your email has been successfully added to our mailing list.

×
0 0 0 0 0 -0.00423213911586001 -0.00649486695998329 -0.00504504504504508
Stock impact report

PHASE 3 STUDY OF NOVEL ANTI-PLATELET DRUG FOR HEART ATTACK REPORTS POSITIVE TOPLINE RESULTS [Yahoo! Finance]

ITOCHU CORP UNSP/ADR (ITOCY) 
NASDAQ:AMEX Investor Relations: itochu.co.jp/en/ir/index.html
Company Research Source: Yahoo! Finance
Disaggpro™ (zalunfiban) has shown positive primary efficacy and primary safety outcomes. The full results from the CeleBrate study will be released on Nov. 10 as part of the late-breaking sessions at the American Heart Association Scientific Sessions in New Orleans. https://bit.ly/47VMxDc CeleBrate logo with red a and lines around a (PRNewsfoto/CeleCor Therapeutics, Inc.) At least 50% of heart-attack deaths occur before the patient reaches the hospital. Even as in-hospital treatment for heart attacks has greatly improved, aspirin is the only antiplatelet treatment routinely used in the U.S. for heart attacks before patients can get to the hospital. Disaggpro was designed to change that, as it can be administered in several pre-hospital settings for rapid treatment of ST-segment elevation (STEMI) heart attacks. The priority in treating STEMI heart attacks is opening the coronary artery as soon as possible after the onset of symptoms to prevent death or irreversible heart damage. Show less Read more
Impact Snapshot
Event Time:
ITOCY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ITOCY alerts
Opt-in for
ITOCY alerts

from News Quantified
Opt-in for
ITOCY alerts

from News Quantified